(Bloomberg) -- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies ...

LONDON, United Kingdom - AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an early-stage trial, with side effects consistent with ...

Virat Kohli and Rohit Sharma came under fire Monday as India chewed over a 3-0 Test series home defeat to New Zealand, with critics calling the team ageing and low on confidence. The cricket ...

Data reported earlier Monday from Viking Therapeutics (NASDAQ:VKTX) on its weight loss medicine VK2735 indicates ... in both as an injectable and in pill form, is most closely related to Lilly's ...

"Losing 3-0 at home is a tough pill to swallow and it calls for introspection," former skipper Sachin Tendulkar wrote on social media. "Was it lack of preparation, was it poor shot selection or ...

Viking Therapeutics shares surge as VK2735 shows significant weight loss in early-stage study, with plans for a phase 2 study by end of 2024. Market cautious ahead of election and Fed decision.